Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Holding TSE:PRN?
Track your performance easily
Earnings Data
Report Date
Mar 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.48Last Year’s EPS
-0.61Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 08, 2018
|% Change Since: -14.57%
|Next Earnings Date:Aug 14, 2018
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and improvements in gross margins, alongside significant achievements in CMS reimbursement upgrades and successful educational events. However, these positives are countered by increased operating expenses and a widening net loss, coupled with slower than expected installations. Overall, the sentiment is positive but tempered by these challenges.Company Guidance
During the Profound Medical Q3 2024 earnings call, key financial metrics included a revenue of $2.83 million, marking a 64% increase from the same period in 2023. The revenue comprised $2.65 million from recurring sources and $179,000 from a one-time sale of capital equipment. The gross margin for Q3 2024 was reported at 64%, up from 61% in Q3 2023, with expectations to maintain or exceed 60% for the full year. Operating expenses rose by 42% to $10.8 million, with R&D, G&A, and sales and distribution expenses increasing by 22%, 84%, and 34% respectively. The net loss for the quarter was $9.4 million, translating to $0.38 per share, compared to a $5.6 million loss or $0.26 per share in Q3 2023. Looking ahead, the company anticipates full-year 2024 revenue to be between $11 million and $12 million.Significant Revenue Growth
Third quarter 2024 revenue increased 64% to $2.83 million compared to $1.73 million in the same period in 2023.
Gross Margin Improvement
Gross margin in Q3 2024 was 64%, up from 61% in Q3 2023.
CMS Reimbursement Upgrade
CMS elevated TULSA facility payment to urology APC Level 7, with a Medicare national average facility payment of $12,992 for hospitals, higher than robotic radical prostatectomy.
Successful PRO-TALK Live Event
The event in Las Vegas was sold out with 70 physicians in attendance, highlighting the TULSA procedure's capabilities and its potential to become a mainstream treatment option.
Positive Market Reaction and Adoption
Following the PRO-TALK Live event, several attending surgeons have adopted the TULSA procedure into their practice.
---
TSE:PRN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:PRN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | C$12.35 | C$11.98 | -3.00% |
| Aug 08, 2024 | C$12.89 | C$13.05 | +1.24% |
| May 09, 2024 | C$11.64 | C$10.56 | -9.28% |
| Mar 07, 2024 | C$12.16 | C$10.89 | -10.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Profound Medical (TSE:PRN) report earnings?
Profound Medical (TSE:PRN) is schdueled to report earning on Mar 11, 2025, TBA Not Confirmed.
What is Profound Medical (TSE:PRN) earnings time?
Profound Medical (TSE:PRN) earnings time is at Mar 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:PRN EPS forecast?
TSE:PRN EPS forecast for the fiscal quarter 2024 (Q4) is -0.48.
---